La inmunidad contra el FVIII vista a través de la teoría del daño
Latin american journal of clinical sciences and medical technology · 2020
DOI: 10.34141/ljcs1899062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Latin american journal of clinical sciences and medical technology, 2020. Verfasst von Rodrígo Arreola-Díaz und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Hemophilia A (HA) is a recessive genetic disease linked to the X chromosome, in which the hemostatic factor VIII (FVIII) is codified. For years, the HA treatment consists of restoring the deficit of such a factor to the patient. The most widely feared complication associated with the treatment is the production of alloantibodies with a neutralizing effect on the FVIII, which inhibits the performance of the factor. Material and Methods. Selective narrative review in PubMed of the terms related to the FVIII inhibitors in articles written in English or Spanish, published between 2000 and 2020.
Results
To carry out this review, we included 59 original and review articles related to the production of HA inhibitors.
Discussion
When the patient starts treatment, the immune system is also beginning to be exposed to an unknown protein. Thus, the production of inhibitors directed against the FVIII starts. The inhibitors affect hemostasis, interfere with union of FVIII to other hemostatic factors, inhibit FVIII activation, block the release the FVIII from the VWF-FVIII complex, or they may rise FVIII prpoteolysis. Inhibitor development depends on the factors related to the patient and the treatment. The anti-VIII response is T-dependent, and the spleen is preponderant. The production of inhibitors may be explained by the danger model and self and non-self. The risk factors of the inhibitors associated with the patient (mutations in F8 and FVIII haplotype) might be related to the last one; the ones pertaining to treatment (doses and the FVIII origin) are associated with the second one.
Zitieren
APA
Arreola-Díaz, R., Hernández-Juárez, J., & Majluf-Cruz, A. (2020). La inmunidad contra el FVIII vista a través de la teoría del daño. Latin american journal of clinical sciences and medical technology. https://doi.org/10.34141/ljcs1899062
Vancouver
Arreola-Díaz R, Hernández-Juárez J, Majluf-Cruz A. La inmunidad contra el FVIII vista a través de la teoría del daño. Latin american journal of clinical sciences and medical technology. 2020. doi:10.34141/ljcs1899062
BibTeX
@article{ArreolaDaz2020,
author = {Arreola-Díaz, Rodrígo and Hernández-Juárez, Jesús and Majluf-Cruz, Abraham},
title = {La inmunidad contra el FVIII vista a través de la teoría del daño},
journal = {Latin american journal of clinical sciences and medical technology},
year = {2020},
doi = {10.34141/ljcs1899062}
}
EUVIMED